National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention/State Key Laboratory for Infectious Disease Prevention and Control, PO Box 5, Changping, Beijing 102206, China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou 310003, China.
National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention/State Key Laboratory for Infectious Disease Prevention and Control, PO Box 5, Changping, Beijing 102206, China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou 310003, China; Pathogenic Biology Institute, University of South China, Hengyang 421001, Hunan Province, China.
Int J Antimicrob Agents. 2015 Feb;45(2):137-43. doi: 10.1016/j.ijantimicag.2014.09.018. Epub 2014 Nov 3.
The emergence of extensively drug-resistant tuberculosis (XDR-TB) in China is a great threat to TB control. To determine the molecular characterisation of XDR-TB isolates from China and the correlations between specific drug resistance-associated mutations and different genotype strains, 58 XDR-TB isolates were sequenced in eight drug loci, including katG, inhA, oxyR-ahpC intergenic region, rpoB, eis, rrs, gyrA and gyrB, and were genotyped using spoligotyping and analysis of the noise transfer function region. Compared with the phenotypic data, the sensitivities and specificities for DNA sequencing were 87.9% and 100.0% for isoniazid (INH), 91.4% and 98.3% for rifampicin (RIF), 60.4% and 100.0% for kanamycin (KAN) and 81.0% and 100.0% for ofloxacin (OFX), respectively. A combination of eight drug loci predicted XDR-TB phenotypes with 53.4% sensitivity (31/58 isolates) and 100.0% specificity. The most frequent mutations among these XDR-TB isolates were katG315 and inhA-15 (for INH), 531, 526 and 516 in rpoB (for RIF), rrs1401 and eis-10 (for KAN) and 94, 90 and 91 in gyrA (for OFX). Also, among these XDR-TB isolates, 44 (75.9%) were identified as Beijing genotype strain, of which 31 (70.5%) belonged to the modern Beijing sublineage. inhA-8, rpoB526 and rpoB531 mutations demonstrated significant statistical associations with ancient and modern Beijing family sublineage (P<0.05). However, Beijing and non-Beijing genotypes showed no association with specific resistance-conferring mutations. These results will be helpful in designing new molecular biology-based techniques to diagnose XDR-TB in China.
中国广泛耐药结核病 (XDR-TB) 的出现对结核病控制构成了巨大威胁。为了确定中国 XDR-TB 分离株的分子特征以及特定耐药相关突变与不同基因型菌株之间的相关性,对 58 株 XDR-TB 分离株的 8 个药物靶位(katG、inhA、oxyR-ahpC 基因间区、rpoB、eis、rrs、gyrA 和 gyrB)进行了测序,并采用 spoligotyping 和噪声传递功能区分析进行了基因分型。与表型数据相比,DNA 测序对异烟肼 (INH) 的敏感性和特异性分别为 87.9%和 100.0%,对利福平 (RIF) 的敏感性和特异性分别为 91.4%和 98.3%,对卡那霉素 (KAN) 的敏感性和特异性分别为 60.4%和 100.0%,对氧氟沙星 (OFX) 的敏感性和特异性分别为 81.0%和 100.0%。8 个药物靶位联合预测 XDR-TB 表型的敏感性为 53.4%(31/58 株),特异性为 100.0%。这些 XDR-TB 分离株中最常见的突变是 katG315 和 inhA-15(用于 INH)、rpoB531、526 和 516(用于 RIF)、rrs1401 和 eis-10(用于 KAN)以及 94、90 和 91(用于 OFX)。此外,在这些 XDR-TB 分离株中,44 株(75.9%)被鉴定为北京基因型菌株,其中 31 株(70.5%)属于现代北京亚谱系。inhA-8、rpoB526 和 rpoB531 突变与古代和现代北京家族亚谱系显著相关(P<0.05)。然而,北京和非北京基因型与特定耐药相关突变无关联。这些结果将有助于设计新的基于分子生物学的技术来诊断中国的 XDR-TB。